Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection
Clinical trial NCT04560569 · UNKNOWN
Trial details
- NCT number
- NCT04560569
- Sponsor
- Frontier Biotechnologies Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2022-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.